Ross Arena
Ross Arena is an expert in Cardiology at University of Illinois at Chicago (United States). As of October 2026, ScienceLeadR ranks Ross Arena in the top 1% of experts worldwide for Heart Failure and Overnutrition. Ross Arena has authored 923 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 2,982 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Sports Medicine - Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr. Arena is a Professor at University of Illinois Chicago, Visiting Scholar at
HealthPartners Institute, and Member of the Roundtable on Obesity Solutions at
the National Academies of Sciences, Engineering, andMedicine. He received his
Ph.D. in Physiology in 2001 from the Medical College of Virginia/Virginia
Commonwealth University. Dr. Arena has over 10 years of experience as an
academic leader. He has been instrumental in the successful implementation of
several innovative healthy living initiatives in the academic, clinical and
community settings and founded the Healthy Living for Pandemic Event
Protection (HL-PIVOT) network in 2020. Dr. Arena’s scholarly interests include:
1) The exploration of ecological drivers of health; 2) Healthy living initiatives that
promote the healthspan; and 3) Exercise testing and training in patient
populations. Dr. Arena has published extensively in these areas with over 1180
peer-reviewed publications, abstracts, and book chapters
Organizations
Career arc: 2000 - 2026
Number : 923
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity NCT05600829 — depression, exercise, psychology, blood, emotions, cardiorespiratory fitness, heart, cardiometabolic risk factors, cardiac rehabilitation, stress, physiological, blood pressure, rehabilitation, prescriptions, risk management, atrial fibrillation, signs and symptoms, psychology, clinical, metabolic equivalent, body weight, obesity, risk factors, tobacco use, research, weight loss, therapeutics, waist circumference, education, random allocation, lipids | N/A | Active not recruiting | 2023 |
| Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) NCT04544293 — pulmonary alveolar proteinosis, granulocyte-macrophage colony-stimulating factor, macrophages, granulocytes, solutions, acetaminophen, macrophage colony-stimulating factor, therapeutics, colony-stimulating factors | Phase 3 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map